Economy
“Hallucinogenic” substances in the spotlight… Why are pharmaceutical companies racing to develop ketamine treatments?
WHAT TO KNOW
CH23: Pharmaceutical companies are racing to develop treatments based on “ketamine,” after the drug emerged as an option for treating depression and mental disorders, amid expectations of major profits from a growing market. According to the American newspaper The New York Times, competition accelerated as the administration of President…
Machine translation of an attributed source excerpt. Consult the original report to verify details. Translated from original reporting in another language.
Reporting timeline
1 outletsReports grouped around the same specific event, ordered by original publication time. Source headlines below retain their original language. Coverage count is not independent confirmation.
